Tag: Enterprises

Browse our exclusive articles!

Democratizing Content Creation: The Transformative Power of Generative AI in Enterprises

Discover how generative AI is revolutionizing content creation for enterprises, streamlining processes, empowering users, and ensuring consistency.

WhyLabs Launches LangKit for Safe and Responsible Large Language Models

WhyLabs unveils LangKit, an open-source technology designed to safeguard large language models. Easy to use and integrate, LangKit helps prevent data leakage and toxic language while accommodating diverse customer needs. Perfect for regulated industries such as healthcare and fintech.

Mistral AI Raises €105M in Europe’s Biggest Seed Funding Round.

Mistral AI secures €105m in Europe's largest-ever seed round, targeting enterprise AI solutions. Developing a large language model which is open-sourced, without legal issues and copyright infringement.

Vietnam’s Tech Giants Show No Interest in ChatGPT

Vietnam's tech giants, including VNG, Vingroup, and BKAV, are yet to rival with ChatGPT, an AI-based chatbot tool that has brought a paradigm shift in AI applications. ChatGPT has become a new market standard, compelling large enterprises to reassess their chatbot development. According to a survey, 48% of enterprises have used ChatGPT, with 25% claiming that it replaces workers and saves thousands of dollars. Although LovinBot and VoiceGPT launched similar chatbots, Vietnam's major tech firms focus on developing their existing AI products, claiming ChatGPT's slow processing speed and high costs than existing AI chatbots.

Low-code machine learning platform Predibase secures $12.2M in funding

Predibase's ML platform raises $12.2M to help developers train and deploy their own LLMs, making building ML applications easy for novices & experts alike.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img